Company: LRHC
Filing Date: 2025-06-03
Form Type: S-1/A
Source: 0001213900-25-050886
Chunk: 9

Company: La Rosa Holdings Corp.
Filing Date: 2025-06-03
Form: S-1/A
Chunk 9
---
 of $1.00 for a minimum of ten consecutive business days during the Compliance Period prior to April
9, 2025.

As of April 8, 2025, the common stock has
not regained compliance with the Bid Price Rule. However, in a letter dated April 9, 2025 (the “Second Nasdaq Bid Price Letter”),
Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180 calendar day
period, or until October 6, 2025, to regain compliance (the “Second Compliance Period”). As of the date of this report our
common stock has not regained compliance with the Bid Price Rule. If the Company chooses to implement a reverse stock split, it must
complete the split no later than ten business days prior to the end of the Second Compliance Period in order to timely regain compliance.
If we fail to regain compliance with the Bid Price Rule within the Second Compliance Period, or if we fail to continue to meet all applicable
continued listing requirements for Nasdaq in the future, Nasdaq could delist our securities.

The Second Nasdaq Bid Price Letter has no
immediate effect on the listing or trading of the common stock. Our common stock continues to be listed on the Nasdaq Capital Market
under the symbol “LRHC”. We are currently evaluating our options for regaining compliance.

Amendment to CEO Employment Agreement

On February 3, 2025, on the approval of the
Compensation Committee of the Board of Directors (the “Compensation Committee”) of the Company amended the employment agreement
between the Company and Joseph La Rosa, the Company’s Chief Executive Officer. The amendment provided Mr. La Rosa with a right
to receive certain annual equity awards and milestone equity awards not only in the form of stock options but also in the form of restricted
stock units and amended Section 4.3(b) to include subsection (vii), according to which for every $1,000,000 raised by the Company through
financing, Mr. La Rosa shall be granted an equity award equal to 2% of the outstanding shares of common stock of the Company.

February 2025 Financing

On February 4, 2025 (the “Closing Date”),
we entered into a securities purchase agreement (the “SPA”) with an institutional investor (“2025 Investor”)
pursuant to which we agreed to issue and sell to 2025 Investor, upon the terms and conditions set forth